EUVIMEDEUVIMED entdecken
Crossref

Biotinylation of human platelets is compatible with pathogen inactivation treatment and cold storage for clinical studies

Charlotte Muret iD, David Crettaz, Agathe Martin, Alessandro Aliotta, Debora Bertaggia Calderara iD, Lorenzo Alberio, Michel Prudent iD

Transfusion · 2025

DOI: 10.1111/trf.18102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Charlotte Muret und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, Epalinges, Switzerland. Hauptthemen laut MEDLINE: Blood Platelets, Blood Preservation, Biotinylation. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Swiss Red Cross humanitarian foundation, Jacques und Gloria Gossweiler-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Production of platelet concentrates (PCs) involves several steps that significantly affect platelet behavior. To gain a deeper understanding of how storage conditions impact donor platelet recirculation and functionality post‐transfusion, ex vivo platelet labeling is a feasible approach. However, before pursuing clinical investigations of platelet recirculation and function in humans, we aimed to determine the effects of pathogen inactivation technology (PIT) and storage conditions (4°C vs. room temperature [RT]) on phenotype and function of biotinylated platelets compared to conventional PIT PCs for transfusion.

Methods

Nine PCs were prepared in 61% additive solution from 45 buffy coats (five buffy coats each). A pool‐and‐split of three units was used to prepare three equivalent PCs: two labeled with biotin and stored at RT or 4°C, and one without labeling and stored at RT. All PCs were then treated by PIT (amotosalen/UVA) and stored for 14 days. Labeling efficiency, platelet concentration, metabolic parameters, aggregation response (ADP, collagen, co‐aggregation with epinephrine), and platelet phenotype (CD42b, CD62‐P, phosphatidylserine) at the basal stage and upon stimulation (ADP or TRAP‐6) were performed.

Results

Labeling efficiency of PIT and 4°C PCs was stable over 14 days of storage. Differences in platelet function and phenotype were mainly due to the storage temperature and not the biotinylation process. Phenotypes at baseline or after stimulation were equivalent in biotin‐positive and biotin‐negative platelets.

Conclusion

Biotin‐labeled platelets can effectively enable investigation of the effects of PIT and storage temperature for clinical studies. This method shows great potential for improving platelet transfusion knowledge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsBlood PreservationBiotinylationHumansPlatelet AggregationCold TemperatureFurocoumarinsUltraviolet Rays

Stichwörter der Autor:innen

biotincold storagelabelingpathogen inactivationplatelet concentrationtransfusion medicine

Substanzen

amotosalenFurocoumarins

Autor:innen und Institutionen

  • Laboratoire de Recherche sur les Produits Sanguins, Transfusion Interrégionale CRS, Epalinges, Switzerland.
  • Laboratoire de Préparation Cellulaire et d'Analyses, Transfusion Interrégionale CRS, Epalinges, Switzerland.
  • Division of Hematology and Central Hematology Laboratory, CHUV, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.

ORCID-Profile: Charlotte Muret, Debora Bertaggia Calderara, Michel Prudent

Förderung

  • Swiss Red Cross humanitarian foundation
  • Jacques und Gloria Gossweiler-Stiftung

Zitieren

APA

Muret, C., Crettaz, D., Martin, A., Aliotta, A., Bertaggia Calderara, D., Alberio, L., & Prudent, M. (2025). Biotinylation of human platelets is compatible with pathogen inactivation treatment and cold storage for clinical studies. Transfusion. https://doi.org/10.1111/trf.18102

Vancouver

Muret C, Crettaz D, Martin A, Aliotta A, Bertaggia Calderara D, Alberio L, et al. Biotinylation of human platelets is compatible with pathogen inactivation treatment and cold storage for clinical studies. Transfusion. 2025. doi:10.1111/trf.18102

BibTeX
@article{Muret2025,
  author = {Muret, Charlotte and Crettaz, David and Martin, Agathe and Aliotta, Alessandro and Bertaggia Calderara, Debora and Alberio, Lorenzo and Prudent, Michel},
  title = {Biotinylation of human platelets is compatible with pathogen inactivation treatment and cold storage for clinical studies},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18102}
}
Kostenlos starten →